Cargando…
Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
Vancomycin‐resistant Enterococcus (VRE) poses a serious threat in hospitals where they densely colonize the intestinal tracts of patients. In vulnerable hosts, these pathogens may translocate to the bloodstream and become lethal. The ability to selectively reduce VRE in the intestinal tracts of pati...
Autores principales: | Geldart, Kathryn G., Kommineni, Sushma, Forbes, Madeline, Hayward, Michael, Dunny, Gary M., Salzman, Nita H., Kaznessis, Yiannis N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195901/ https://www.ncbi.nlm.nih.gov/pubmed/30377660 http://dx.doi.org/10.1002/btm2.10107 |
Ejemplares similares
-
Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019) -
Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023) -
Antimicrobial Probiotics Reduce Salmonella enterica in Turkey Gastrointestinal Tracts
por: Forkus, Brittany, et al.
Publicado: (2017) -
Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017) -
Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)